I

Innoviva

D
INVA
USD
0.13
(0.6656%)
Market Closed
10,816.00
Volume
2.24
EPS
-
Div Yield
11.107
P/E
1,229,978,651.70
Market Cap
Today
0.6656%
1 Week
0.112%
1 Month
6.156%
6 Months
34.335%
12 Months
57.343%
Year To Date
22.722%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
E
EXAS
1.61
(2.3256%)
USD
G
GH
0.3
(1.1952%)
USD
T
TDOC
0.065
(0.7135%)
USD
F
FATE
0.12
(3.0928%)
USD
R
RARE
1.17
(2.0316%)
USD
A
ALNY
3.06
(1.1203%)
USD
A
ARWR
0.35
(1.6851%)
USD
E
EXEL
0.03
(0.1119%)
USD
I
ILMN
3.34
(2.5496%)
USD
N
NVTA
(%)
USD
REGN
REGN
11.33
(0.9948%)
USD

Title:
Innoviva

Sector:
Healthcare
Industry:
Biotechnology
Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
Do you need help or have a question?
Contact Us